Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
about
The promigratory activity of the matricellular protein galectin-3 depends on the activation of PI-3 kinase.Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer.Biomarkers for anti-angiogenic therapy in cancer.Application of metabolomics in thyroid cancer research.Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays.Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.UH cancer center hotline: thyroid cancer: rising incidence and ethnic disparitiesIntegrative metabonomics as potential method for diagnosis of thyroid malignancyThe role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.Ras oncoprotein disrupts the TSH/CREB signaling upstream adenylyl cyclase in human thyroid cell.Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: validation of molecular markers and technology innovation.Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter.Identification of novel diagnostic biomarkers for thyroid carcinoma.Utility of molecular testing in the management of thyroid nodules - a clinical perspective.Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer.
P2860
Q34117467-270F6596-5E94-4FB9-BEC4-5F23D57D0543Q34472131-5579DE83-EA41-480F-9684-7254ACBD4F24Q34695003-4FC86749-2D2A-4966-A871-1810C3E9296AQ35564078-F7772590-7E42-41E7-A1FF-DCE450CC9D4DQ35690041-01448F2C-80FD-43BA-81D3-1DD1931B9047Q35925897-720E0F74-A12B-4842-952C-AA560E2E1CF3Q35969385-475041C0-8448-4BF3-AA6A-92912855C345Q36166375-03509140-D255-4086-8A66-9194E2600F93Q36184786-0F743205-369B-4C73-9968-A343ADA5AE0EQ37857025-3DCDBAE7-C093-42F8-8A17-B1B175B791CDQ38995868-B8CB0559-7B65-473F-ACC0-E01BC17F32DBQ44053611-9875F05F-15D5-4225-AD7A-6B3E3916CC2FQ44518982-9236DD61-49A1-408D-A1C7-1BC279C70677Q50017200-DC3C7E4E-B73F-4A83-82F1-C992B12FA42CQ53334940-06C7329E-12DC-4076-B4D0-072451F90D7CQ54324154-7D6E5819-AC51-4444-868C-B9A418A77F59
P2860
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
@en
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
@nl
type
label
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
@en
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
@nl
prefLabel
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
@en
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
@nl
P2093
P2860
P356
P1476
Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
@en
P2093
Andrea Nicolini
Angelo Carpi
Jeffrey I Mechanick
Sven Saussez
P2860
P304
P356
10.1002/JCP.22187
P577
2010-09-01T00:00:00Z